- Home
- BLUE vs ECOR Comparison
BLUE vs ECOR Comparison
Compare BLUE & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLUE
- ECOR
- Stock Information
- Founded
- BLUE 1992
- ECOR 2005
- Country
- BLUE United States
- ECOR United States
- Employees
- BLUE N/A
- ECOR N/A
- Industry
- BLUE Biotechnology: Biological Products (No Diagnostic Substances)
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- BLUE Health Care
- ECOR Health Care
- Exchange
- BLUE Nasdaq
- ECOR Nasdaq
- Market Cap
- BLUE 78.7M
- ECOR 65.0M
- IPO Year
- BLUE 2013
- ECOR 2018
- Fundamental
- Price
- BLUE $8.50
- ECOR $14.89
- Analyst Decision
- BLUE Hold
- ECOR Strong Buy
- Analyst Count
- BLUE 9
- ECOR 1
- Target Price
- BLUE $49.14
- ECOR $25.00
- AVG Volume (30 Days)
- BLUE 729.7K
- ECOR 138.3K
- Earning Date
- BLUE 11-14-2024
- ECOR 11-13-2024
- Dividend Yield
- BLUE N/A
- ECOR N/A
- EPS Growth
- BLUE N/A
- ECOR N/A
- EPS
- BLUE N/A
- ECOR N/A
- Revenue
- BLUE $53,120,000.00
- ECOR $23,327,000.00
- Revenue This Year
- BLUE $152.71
- ECOR $61.40
- Revenue Next Year
- BLUE $233.91
- ECOR $38.43
- P/E Ratio
- BLUE N/A
- ECOR N/A
- Revenue Growth
- BLUE 144.50
- ECOR 74.10
- 52 Week Low
- BLUE $5.80
- ECOR $5.25
- 52 Week High
- BLUE $38.40
- ECOR $17.84
- Technical
- Relative Strength Index (RSI)
- BLUE 50.43
- ECOR 59.13
- Support Level
- BLUE $5.97
- ECOR $14.11
- Resistance Level
- BLUE $9.75
- ECOR $17.84
- Average True Range (ATR)
- BLUE 2.04
- ECOR 1.47
- MACD
- BLUE 0.07
- ECOR 0.16
- Stochastic Oscillator
- BLUE 26.83
- ECOR 47.76
About BLUE bluebird bio Inc.
bluebird bio Inc is a biotechnology company engaged in researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector (LVV) gene addition platform. The Company operates in a single segment, focusing on researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases.
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.